Suppr超能文献

与人类上皮样肉瘤体外侵袭性相关的差异表达基因。

Differentially expressed genes in association with in vitro invasiveness of human epithelioid sarcoma.

作者信息

Weber A, Engers R, Nockemann S, Gohr L L, Zur Hausen A, Gabbert H E

机构信息

Institute of Pathology, Heinrich-Heine-University, Moorenstr. 5, D-40225 Duesseldorf, Germany.

出版信息

Mol Pathol. 2001 Oct;54(5):324-30. doi: 10.1136/mp.54.5.324.

Abstract

AIMS

Differential display reverse transcription polymerase chain reaction (RT-PCR) was performed to identify genes associated with the invasive potential of human epithelioid sarcoma.

METHODS

Two different clonal subpopulations, GRU-1A and GRU-1B, derived from the same human epithelioid sarcoma cell line GRU-1 and known to differ greatly in their invasive potential were compared by means of mRNA fingerprinting.

RESULTS

Using a set of 10 arbitrary upstream primers and nine anchored oligo-dT primers, 22 candidate gene fragments were identified; differential expression was confirmed in four of these fragments by northern blot analysis. At the mRNA level, apoferritin light chain was predominantly expressed by the highly invasive cell line GRU-1A. In contrast, the mitochondrial gene M1, encoding cytochrome c oxidase I, and the TI-227H gene were expressed more strongly by the low invasive cell line GRU-1B. Furthermore, a novel gene fragment was identified and cloned that was preferentially expressed in the low invasive cell line GRU-1B, and therefore might have an inhibitory role in invasion. Consequently, this gene fragment was designated as expressed in low invasive sarcoma cells (ELISC-1).

CONCLUSIONS

A novel gene fragment (ELISC-1) and three known genes were identified as potential regulators of tumour invasiveness. Cloning of the entire sequence of ELISC-1 and subsequent investigations are required to establish its biological role.

摘要

目的

采用差异显示逆转录聚合酶链反应(RT-PCR)来鉴定与人类上皮样肉瘤侵袭潜能相关的基因。

方法

通过mRNA指纹图谱比较了源自同一人类上皮样肉瘤细胞系GRU-1的两个不同克隆亚群GRU-1A和GRU-1B,已知它们的侵袭潜能差异很大。

结果

使用一组10条随机上游引物和9条锚定寡聚dT引物,鉴定出22个候选基因片段;通过Northern印迹分析在其中4个片段中证实了差异表达。在mRNA水平上,脱铁铁蛋白轻链主要由高侵袭性细胞系GRU-1A表达。相比之下,编码细胞色素c氧化酶I的线粒体基因M1和TI-227H基因在低侵袭性细胞系GRU-1B中表达更强。此外,鉴定并克隆了一个新的基因片段,该片段在低侵袭性细胞系GRU-1B中优先表达,因此可能在侵袭中起抑制作用。因此,该基因片段被命名为低侵袭性肉瘤细胞中表达的基因(ELISC-1)。

结论

一个新的基因片段(ELISC-1)和三个已知基因被鉴定为肿瘤侵袭的潜在调节因子。需要克隆ELISC-1的完整序列并进行后续研究以确定其生物学作用。

相似文献

本文引用的文献

7
Cloning differentially expressed mRNAs.克隆差异表达的信使核糖核酸
Nat Biotechnol. 1996 Dec;14(13):1685-91. doi: 10.1038/nbt1296-1685.
8
Minimizing false positives in differential display.最小化差异显示中的假阳性
Biotechniques. 1998 May;24(5):766-8, 770. doi: 10.2144/98245bm16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验